Marianne Mertens

Board Observer at Auron Therapeutics

Marianne is a Partner at Apollo Health Ventures and responsible for Apollo’s investment and company building activities. Prior to joining the Apollo team, Marianne was a Principal with Wellington Partners, a pan-European Venture Capital firm investing in early- and growth-stage Life Science companies. In this role she led Wellington’s investments in Confo Therapeutics and Imcheck Therapeutics, and supported portfolio companies across different stages of development. Before Wellington Marianne was an Investment Manager in the Life Science Team of HTGF where she managed a portfolio of seven portfolio companies. Earlier in her career Marianne worked as a management consultant and supported pharmaceutical and medtech companies relative to strategy, portfolio and business unit development.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Auron Therapeutics

1 followers

Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to the transformation of malignant cells into more normal functioning cells.


Industries

Employees

11-50

Links